Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CureVac (CVAC)
NASDAQ:CVAC
CureVac (CVAC) Stock Price & Analysis
1,091 Followers
CVAC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.54 - $12.36
Previous Close$2.57
Volume712.93K
Average Volume (3M)778.81K
Market Cap
$575.38M
Enterprise Value$121.67M
Total Cash (Recent Filing)€495.80M
Total Debt (Recent Filing)€42.09M
Price to Earnings (P/E)-1.7
Beta0.97
Next Earnings
Apr 24, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.53
Shares Outstanding223,841,600
10 Day Avg. Volume992,406
30 Day Avg. Volume778,813
Standard Deviation0.29
R-Squared0.19
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)1.25
Price to Sales (P/S)8.53
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
CureVac News
PremiumCompany Announcements
CureVac Partners with MD Anderson on Cancer Vaccines
PremiumCompany Announcements
CureVac’s Influenza Vaccine Shows Strong Phase 2 Results
Ownership Overview
0.00% Insiders
1.14% Mutual Funds
1.23% Other Institutional Investors
97.64% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CVAC FAQ
What was CureVac’s price range in the past 12 months?
CureVac lowest stock price was $2.54 and its highest was $12.36 in the past 12 months.
What is CureVac’s market cap?
Currently, no data Available
When is CureVac’s upcoming earnings report date?
CureVac’s upcoming earnings report date is Apr 24, 2024 which is in 5 days.
How were CureVac’s earnings last quarter?
CureVac released its earnings results on Nov 14, 2023. The company reported -$0.235 earnings per share for the quarter, beating the consensus estimate of -$0.24 by $0.005.
Is CureVac overvalued?
According to Wall Street analysts CureVac’s price is currently Overvalued.
Does CureVac pay dividends?
CureVac does not currently pay dividends.
What is CureVac’s EPS estimate?
CureVac’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CureVac have?
CureVac has 223,883,090 shares outstanding.
What happened to CureVac’s price movement after its last earnings report?
CureVac reported an EPS of -$0.235 in its last earnings report, beating expectations of -$0.24. Following the earnings report the stock price went up 2.722%.
Which hedge fund is a major shareholder of CureVac?
Among the largest hedge funds holding CureVac’s share is RA Capital Management. It holds CureVac’s shares valued at 12M.
---
CureVac Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Company Description
CureVac
CureVac BV a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. The company's product portfolio includes clinical and preclinical candidates across multiple disease indications in oncology, prophylactic vaccines and protein therapy. Its clinical programs are CV8102, which it is evaluating in a Phase 1 clinical trial for the treatment of four types of solid tumors, and CV7202, which it is investigating in a Phase 1 clinical trial for potential vaccination against rabies. It is also rapidly advancing its mRNA vaccine program against coronavirus SARS- CoV-2), for which the company initiated a Phase 1 clinical trial.
---
CVAC Company Deck
---
CVAC Earnings Call
Q3 2023
0:00 / 0:00
---
CVAC Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering CVAC
1 Year
1 Year Success Rate
1/17 ratings generated profit
1 Year Average Return
-55.01%
reiterated a buy rating 11 months ago
Copying Zhiqiang Shu's trades and holding each position for 1 Year would result in 5.88% of your transactions generating a profit, with an average return of -55.01% per trade.
---